National Science Foundation
VC Fund
Alexandria, United States
National Science Foundation is a VC fund in Alexandria focused on Health Care and Biotechnology. The National Science Foundation supports research and education in science and engineering through grants and non-dilutive funding programs. It offers financial support to startups developing science and technology innovations, particularly through early-stage research and development efforts.Through America's Seed Fund, authorized underthe Small Business Innovation Research program, the foundation provides resources to mitigate technical risks and advance commercially viable technologies. Funding spans a wide range of scientific and engineering disciplines and is aimed at fostering innovation and long-term impact in both academia and industry.The foundation manages a substantial annual budget to sustain fundamental research and expand educational opportunities in the sciences.
- Total investments:
- 3650
- Last investment:
- Lead investor:
- 96%
- Fund size:
- $1.5M
- Last fund:
Last updated:
For AI agents: llms.txt
Industries National Science Foundation invests in
Stages National Science Foundation invests in
Countries National Science Foundation invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
| See all 23 contacts → | |||
Investment Focus
Industry
- Health Care 561 (15%)
- Biotechnology 524 (14%)
- Manufacturing 367 (10%)
- Software 355 (10%)
- Medical 297 (8%)
Stage
- Grant 2612 (72%)
- Seed 22 (1%)
- Pre-Seed 14 (0%)
- Non-equity Assistance 5 (0%)
- Series B 3 (0%)
Country
- United States 2577 (71%)
- Puerto Rico 7 (0%)
- United Kingdom 6 (0%)
- Canada 3 (0%)
- China 2 (0%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Florence Hudson
NSF Panelist / Reviewer
|
NSF Panelist / Reviewer | Total investments: 0 | Find email | |
|
Rick Rashid
Member
|
Member | Total investments: 0 | Find email | |
|
Amy Northcutt
Chief Information Officer and Chief Privacy Officer
|
Chief Information Officer and Chief Privacy Officer | Total investments: 0 | Find email | |
|
Christian Theriault
Grant Reviewer - NSF SBIR/STTR Program | Div. of Industrial Innovation and Partnerships (IIP)
|
Grant Reviewer - NSF SBIR/STTR Program | Div. of Industrial Innovation and Partnerships (IIP) | Total investments: 3 | Find email | |
|
Cora B. Marrett
Acting Director
|
Acting Director | Total investments: 0 | Find email | |
| See all 23 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
|
|
Informuta's objective is to provide next-generation diagnostics, tracking, identification, and treatment for antibiotic-resistant illnesses. Informuta's objective is to provide next-generation diagnostics, tracking, identification, and treatment for antibiotic-resistant illnesses. | $1.3M / Grant / Sep 23, 2026 | |
| Manufacturer of wireless charging systems based in Lafayette, Colorado. The company is currently operating in stealth mode. | $1.3M / Grant / Sep 22, 2026 | ||
| Sunthetics enables process chemists in pharma to develop electrochemical lead molecules in 1/10th of the time. Electrochemistry has many operational, cost, and sustainable benefits such as using 40% less energy, avoiding toxic chemicals and waste, and enabling new types of molecules. Despite interest in pharmaceuticals to developelectrochemical molecules, many molecules don't make it past process development. For most applications, the many years of optimization and additional training required don't justify the energy and cost savings. Sunthetics develops smart electrochemical reactors that enable process chemists to develop at-scale processes in 1/10th of the time. Our effective hardware is scalable and effective, and enables fast results through a machine-learning platform that is automatic and predictive, reducing the experiments needed for development by 10x. Though the beachhead market is pharmaceuticals, Sunthetics has a platform technology that can be scaled and applied to follow-on markets such as agrochemicals and specialty chemicals, spearheading the electrification of the chemical industry. | $19.5M / Grant / Aug 26, 2026 | ||
| CerFlux offers personalized medicine technology for matching treatments to tumors that aim to improve outcomes and quality of life while reducing the time, the pain, and the cost of cancer treatment. | $1.3M / Grant / Aug 23, 2026 | ||
| Colleague AI is an Educational Platform. | $1.3M / Grant / Aug 19, 2026 | ||
| PureLi is a cleantech company that boosts lithium extraction and production from brine sources. | $5M / Grant / Aug 12, 2026 | ||
| Beken Bio develops surgical fluid tests that help diagnose cancer. | $1.3M / Grant / Aug 11, 2026 | ||
| Opal Therapeutics is building a uterine organoid-based discovery platform to address critical gaps in reproductive health R&D. Conditions like endometriosis and fibroids affect over 100 million women worldwide, yet there are few effective therapies and no cures. A major barrier has been reliance on rodent models, which fail to capture thehormonal, cellular, and immune complexity of the human uterus, leading to poor clinical translation. Rodents don’t even have a menstrual cycle. Opal collects menstrual blood and uterine biopsies from diverse donors to generate a biobank of uterine organoids and assembloids that model human tissue function and disease. These 3D cultures retain key cell types and disease phenotypes and are assayed for morphology, cytokines, and gene expression. This platform supports high-resolution disease modeling, tox screening, and non-hormonal drug screening, offering a scalable and human-specific alternative to animal testing in women’s health. Our goal is to close the translational gap and accelerate therapeutic discovery in historically neglected gynecologic disorders. | $1.3M / Grant / Aug 06, 2026 | ||
| Life Seal Vascular provides sealing technologies for endovascular repair of aortic aneurysms. | $1.3M / Grant / Aug 06, 2026 | ||
| PaveX is an AI-powered infrastructure technology company that helps communities monitor and manage road conditions. | $305K / Grant / Aug 04, 2026 | ||
| See all 3650 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does National Science Foundation invest in?
National Science Foundation invests primarily in Health Care, Biotechnology and Manufacturing startups, most often at Grant and Seed stage. Most of the 3,650 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact National Science Foundation?
Public channels for National Science Foundation include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at National Science Foundation?
The team at National Science Foundation includes Florence Hudson (NSF Panelist / Reviewer), Rick Rashid (Member) and Amy Northcutt (Chief Information Officer and Chief Privacy Officer), among 23 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!